Phase I Cancer Clinical Trials

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6603702
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials

Clinical Genitourinary Cancer
OncologyUrology
2014English

Escalation With Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials

PLoS ONE
Multidisciplinary
2014English

A Dynamic Stopping Rule for Phase I Clinical Trials

Biometrical Letters
2018English

Phase I Clinical Trials in 85 Patients With Gynecologic Cancer: The M. D. Anderson Cancer Center Experience

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

Outcomes of Research Biopsies in Phase I Clinical Trials: The MD Anderson Cancer Center Experience

Oncologist
Cancer ResearchMedicineOncology
2011English

The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials

Journal of Cancer
Oncology
2012English

Choice of Starting Dose for Biopharmaceuticals in First-In-Human Phase I Cancer Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2015English

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2017English

P1.01-26 Single-Centre Experience of Clinical Outcomes for Advanced Lung Cancer Patients in Phase I Clinical Trials

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy